Search

Your search keyword '"Biselli, Maurizio"' showing total 206 results

Search Constraints

Start Over You searched for: Author "Biselli, Maurizio" Remove constraint Author: "Biselli, Maurizio"
206 results on '"Biselli, Maurizio"'

Search Results

1. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

2. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

3. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

4. Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

6. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

7. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib

9. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding

11. Magnetic Resonance Enterography Reinvented: Exploring the Potential of a New Natural Beverage as an Alternative to Polyethylene Glycol Solution

12. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

13. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

14. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

15. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma

16. The evolutionary scenario of hepatocellular carcinoma in Italy: an update

17. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

18. The Gastropack Access System as a Model to Access Gastroenterology Services for Gastroscopy Appropriateness in Patients with Upper Gastrointestinal Symptoms: A Comparison with the Open Access System.

19. Monofocal hepatocellular carcinoma: How much does size matter?

21. Years of life that could be saved from prevention of hepatocellular carcinoma

22. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome

23. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

29. Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study

30. Tu1136 THE GASTROPACK SYSTEM AS A MODEL FOR EGD APPROPRIATENESS IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS: A COMPARISON WITH THE OPEN ACCESS SYSTEM

36. Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor

39. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma

42. New MRI series for kidney evaluation: Saving time and money

43. Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

44. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma: an Italian experience

46. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm

47. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome

48. Prognosis of untreated hepatocellular carcinoma

49. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group

50. Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database

Catalog

Books, media, physical & digital resources